awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q35848351-12EFF24E-8029-43C5-A577-2DD65EECD3F6
Q35848351-12EFF24E-8029-43C5-A577-2DD65EECD3F6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35848351-12EFF24E-8029-43C5-A577-2DD65EECD3F6
A phase 1/2 trial of high-dose yttrium-90-ibritumomab tiuxetan in combination with high-dose etoposide and cyclophosphamide followed by autologous stem cell transplantation in patients with poor-risk or relapsed non-Hodgkin lymphoma
P2860
Q35848351-12EFF24E-8029-43C5-A577-2DD65EECD3F6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35848351-12EFF24E-8029-43C5-A577-2DD65EECD3F6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7c9344bd7049e5385131e0435d414749dbba1aac
P2860
Multicenter phase II study of iodine-131 tositumomab for chemotherapy-relapsed/refractory low-grade and transformed low-grade B-cell non-Hodgkin's lymphomas.